Medpace Holdings Inc

Healthcare · Diagnostics & Research

635.00$ -3.3% vs. previous close Closing price · As of: Nov 5, 2026

Statements

Income Statement

Medpace Holdings Inc (MEDP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Revenue" came in at 716 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MEDP
Line item	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	LTM
Revenue	498	511	528	533	537	559	603	660	708	707	707	716	2,838
Cost of Revenue	362	356	374	364	358	380	423	463	503	510	506	492	2,011
Gross Profit	137	155	154	169	178	178	180	197	205	196	202	224	827
Selling, General & Administrative	41	44	41	49	44	58	47	48	45	48	48	52	193
Total Operating Expenses	49	51	49	57	53	65	54	55	52	55	55	58	220
Operating Income	87	104	105	112	125	114	126	142	153	142	147	166	607
Interest Expense	1.8	4.1	5.5	7.5	7.9	–	–	–	–	–	–	–	–
Pre-Tax Income	91	113	110	119	134	118	125	143	157	148	152	171	627
Income Tax Expense	12	10	22	22	17	3.6	34	32	22	24	30	33	109
Net Income	78	103	88	96	117	115	90	111	135	124	121	137	518
EBITDA	96	120	118	126	141	125	132	150	164	154	148	177	644

LTM = last twelve months (sum of the four most recent quarters).

Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings